A comparative trial of amitriptyline and zimelidine in post-herpetic neuralgia
- 1 December 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 23 (4) , 387-394
- https://doi.org/10.1016/0304-3959(85)90009-0
Abstract
Serotoninergic pathways are believed to be important in pain mechanisms. Accordingly, we studied the action of zimelidine, a very highly serotoninergic antidepressant, in relieving the pain of post-herpetic neuralgia. Fifteen patients receivied zimelidine and amitriptyline in that order in an open-label cross-over study. Only one patient with zimelidine obtained a good result, whereas 8 patients on amitriptyline had a good result or better (P < 0.02). We conclude that amitriptyline has a pain-relieving action, at least in post-herpetic neuralgia, which is not primarily linked with its serotoninergic effects and which is also independent of its effects on depression.This publication has 13 references indexed in Scilit:
- Amitriptyline potentiates morphine analgesia by a direct action on the central nervous systemAnnals of Neurology, 1983
- A controlled study of amitriptyline in the treatment of chronic painPain, 1982
- ZimelidineDrugs, 1982
- Amitriptyline versus placebo in postherpetic neuralgiaNeurology, 1982
- Amitriptyline and perphenazine (Triptafen DA) in chronic painAnaesthesia, 1981
- A double-blind controlled study of a serotonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patientsPain, 1979
- Clomipramine and Amitriptyline in the Treatment of Severe PainInternational Journal of Neuroscience, 1979
- Amitriptyline in the prophylaxis of migraineNeurology, 1976
- Relief of postherpetic neuralgia with psychotropic drugsJournal of Neurosurgery, 1973
- The treatment of chronic pain with psychotropic drugsPostgraduate Medical Journal, 1972